Listen "Andreas Hochhaus, MD, Talks About the ASCEMBL Trial, Eliminating LSCs in CML"
Episode Synopsis
In this podcast, Andreas Hochhaus, MD, University Medical Center Jena, Germany, discusses the significance of the ASCEMBL trial presented at the virtual 2020 ASH Annual Meeting and Exposition, and proposes the question of how to eliminate persisting leukemic stem cells (LSCs) in chronic myeloid leukemia (CML).
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.